Cargando…
Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
Heart failure (HF) is a worldwide pandemic with an unacceptable high level of morbidity and mortality. Understanding the different pathophysiological mechanisms will contribute to prevention and individualized therapy of HF. We established mouse models for ischemic cardiomyopathy (ICM) and dilated c...
Autores principales: | Lu, Danbo, Xia, Yan, Chen, Zhangwei, Chen, Ao, Wu, Yuan, Jia, Jianguo, Sun, Aijun, Zou, Yunzeng, Qian, Juying, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591471/ https://www.ncbi.nlm.nih.gov/pubmed/31275164 http://dx.doi.org/10.3389/fphys.2019.00750 |
Ejemplares similares
-
Proteomics Analysis of Myocardial Tissues in a Mouse Model of Coronary Microembolization
por: Chen, Ao, et al.
Publicado: (2018) -
Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
por: Chen, Ao, et al.
Publicado: (2021) -
Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy
por: Liu, Muyin, et al.
Publicado: (2023) -
In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy
por: Liu, Shanshan, et al.
Publicado: (2017) -
Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization
por: Ma, Jianying, et al.
Publicado: (2012)